Please enter a valid ZIP code

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) works for many types of bleeds

  • Provides fast bleed Bleed
    In hemophilia, a collection of blood in an area, such as a muscle or joint.
    control for hemophilia A or B with inhibitors Hemophilia with inhibitors
    A bleeding disorder where the body fights against the factor used to treat hemophilia.
    . Learn more
  • The only bypassing agent Bypassing agent
    A product that treats a bleed without the need for Factor VIII (8) or Factor IX (9).
    approved for the treatment of acquired hemophilia Acquired hemophilia
    A form of hemophilia in which the body starts producing antibodies that fight its own blood-clotting proteins.
    . Learn more
  • Effective treatment of congenital factor VII deficiency Congenital factor VII (7) deficiency
    A bleeding disorder in which there are low levels of Factor VII in the blood.
    . Learn more
  • Effective bleed control for people with Glanzmann's thrombasthenia who have a decreased or absent response to platelet transfusions. Learn more
  • Controls Control
    In hemophilia, to cause reduction in something, such as swelling or bleeding.
    bleeds during and after surgery. Learn more
Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.